BHFAM — Brighthouse Financial, Inc.

Brighthouse Financial (BHFAM) Q2 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Adjusted Earnings: Reported at $198 million ($3.43 per share), down from $245 million in Q1 2025 and $346 million in Q2 2024.
• Total Annuity Sales: $2.6 billion, a 16% sequential increase and an 8% year-over-year increase. Shield sales were $1.9 billion, contributing to year-to-date Shield sales of $3.9 billion.
• Life Insurance Sales: $33 million in Q2, leading to record year-to-date sales of $69 million, a 21% increase compared to the same period in 2024.
• Combined Risk-Based Capital (RBC) Ratio: Estimated between 405% and 425%, within the target range of 400% to 450%.
• Total Adjusted Capital (TAC): Approximately $5.6 billion, up from $5.5 billion in Q1 2025.
• Corporate Expenses: $202 million, down from $239 million in Q1 2025.

2. Strategic Updates and Business Highlights

• Continued focus on capital efficiency and unlocking capital through strategic initiatives.
• Execution of a revised hedging strategy for variable annuities and Shield products, expected to enhance risk management and transparency.
• Strong performance in distribution and sales, particularly through BlackRock's LifePath Paycheck product, which generated $176 million in deposits.
• Shareholder returns included $43 million in stock repurchases, totaling $102 million year-to-date, with $441 million remaining under the repurchase program.

3. Forward Guidance and Outlook

• Management remains committed to maintaining a strong capital position and liquidity, with a focus on expense discipline.
• Anticipation of continued strong sales performance, particularly in annuities and life insurance, with no immediate changes to business strategy.
• Future cash flow projections are not expected until after the completion of ongoing strategic initiatives, likely in 2026.

4. Bad News, Challenges, or Points of Concern

• Adjusted earnings fell significantly below expectations due to lower alternative investment income and a reduced underwriting margin, with mortality claims higher than anticipated.
• The company faces competitive pressures in the annuity market, particularly affecting Shield sales, which saw a decline for the first time in years.
• Concerns regarding the negative unassigned surplus in BLIC, which remains around -$2 billion, and its potential impact on cash distributions.
• The RBC ratio is expected to decline due to seasonal capital charges and adverse non-VA results.

5. Notable Q&A Insights

• Management clarified that the actuarial review process is ongoing, with no immediate updates available.
• The transition to a separate hedging strategy for VA and Shield products is expected to simplify operations and reduce volatility, though the immediate impact on capital ratios is not anticipated to be significant.
• Discussions around buybacks indicate a pause since May 2025, with future repurchases dependent on market conditions and capital needs.
• The company is focused on maintaining operational independence and flexibility, with ongoing evaluations of reinsurance opportunities to enhance capital efficiency.
• Management acknowledged heightened claims severity in both Life and Run-off segments, attributing it to fluctuations in mortality experience.

This summary encapsulates the key aspects of Brighthouse Financial's Q2 2025 earnings call, highlighting financial performance, strategic initiatives, and challenges faced by the company.